These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 1482424)

  • 1. Involvement of cannabinoid receptors in depression of the putative nociceptive response in spinal cord preparations isolated from neonatal rats.
    Tsuzawa K; Onimaru H; Inagaki K; Izumizaki M
    J Physiol Sci; 2023 Oct; 73(1):23. PubMed ID: 37803279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eperisone Hydrochloride, a Muscle Relaxant, Is a Potent P2X7 Receptor Antagonist.
    Okada M; Nose T
    Chem Pharm Bull (Tokyo); 2024; 72(3):345-348. PubMed ID: 38556262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle Strength Decline Caused by Eperisone Hydrochloride: A Case Report.
    Zhu J; Xiao J; Hu J; Shen J; Chen B; Zhao C
    Clin Ther; 2024 Jan; 46(1):74-78. PubMed ID: 37914584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal Reflexes and Windup In Vitro: Effects of Analgesics and Anesthetics.
    Rivera-Arconada I; Roza C; Lopez-Garcia JA
    CNS Neurosci Ther; 2016 Feb; 22(2):127-34. PubMed ID: 26384473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects.
    Quasthoff S; Möckel C; Zieglgänsberger W; Schreibmayer W
    CNS Neurosci Ther; 2008; 14(2):107-19. PubMed ID: 18482024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.
    Wagstaff AJ; Bryson HM
    Drugs; 1997 Mar; 53(3):435-52. PubMed ID: 9074844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tizanidine: neuropharmacology and mechanism of action.
    Coward DM
    Neurology; 1994 Nov; 44(11 Suppl 9):S6-10; discussion S10-1. PubMed ID: 7970012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of centrally acting myorelaxants on NMDA receptor-mediated synaptic transmission in the immature rat spinal cord in vitro.
    Siarey RJ; Long SK; Evans RH
    Br J Pharmacol; 1992 Oct; 107(2):628-33. PubMed ID: 1330190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression of primary afferent-evoked responses by GR71251 in the isolated spinal cord of the neonatal rat.
    Guo JZ; Yoshioka K; Yanagisawa M; Hosoki R; Hagan RM; Otsuka M
    Br J Pharmacol; 1993 Nov; 110(3):1142-8. PubMed ID: 7507777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The excitatory and inhibitory modulation of primary afferent fibre-evoked responses of ventral roots in the neonatal rat spinal cord exerted by nitric oxide.
    Kurihara T; Yoshioka K
    Br J Pharmacol; 1996 Aug; 118(7):1743-53. PubMed ID: 8842440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tail-pinch method in vitro and the effects of some antinociceptive compounds.
    Yanagisawa M; Murakoshi T; Tamai S; Otsuka M
    Eur J Pharmacol; 1984 Nov; 106(2):231-9. PubMed ID: 6152216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a tachykinin antagonist on a nociceptive reflex in the isolated spinal cord-tail preparation of the newborn rat.
    Otsuka M; Yanagisawa M
    J Physiol; 1988 Jan; 395():255-70. PubMed ID: 2457677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effects of tizanidine, diazepam and eperisone in isolated spinal cord-tail preparations of newborn rat.
    Ishizuki M; Yanagisawa M
    Pain; 1992 Jan; 48(1):101-106. PubMed ID: 1482424
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.